About

Professor Mansoor A. Khan is associated with the Irma Lerma Rangel College of Pharmacy at Texas A&M University. The provided page text does not include specific details about his research focus, background, or key contributions. Therefore, no detailed biography information is available from the given content.

Research topics

• Medicine
• Chemistry
• Organic chemistry
• Pharmacology
• Internal medicine
• Biochemistry
• Nuclear chemistry
• Chromatography
• Surgery
• Computer Science
• General surgery
• Process engineering
• Materials science
• Intensive care medicine
• Medical education
• Medical emergency
• Nanotechnology
• Chemical engineering
• Emergency medicine
• Engineering

Selected publications

• Deep-fake Exposure, Artificial Intelligence and Online Harassment among Generation-Z in Pakistan: A Quantitative Study of Awareness, Victimization and Psychological Impact

  Open MIND · 2026-01-24

  articleSenior author
  DOI

• Effect of Process and Formulation Variables on Quality, Stability, and Taste of Lamivudine Printlets Manufactured by Binder Jetting 3D Printing Method

  AAPS PharmSciTech · 2026-01-08

  articleOpen accessSenior author
  PublisherOA PDFDOI

• Behavioral Characteristics of Low Self-Control among Generation-Z: A Qualitative Study

  Open MIND · 2026-01-29

  articleSenior author
  DOI

• Behavioral Characteristics of Low Self-Control among Generation-Z: A Qualitative Study

  Zenodo (CERN European Organization for Nuclear Research) · 2026-01-29

  articleOpen accessSenior author
  PublisherDOI

• Cybercrime Awareness, Legal Literacy and Reporting Behavior among Generation-Z in Pakistan: Gendered Patterns and Policy Implications

  Zenodo (CERN European Organization for Nuclear Research) · 2026-02-02

  articleOpen accessSenior author
  PublisherDOI

• Deep-fake Exposure, Artificial Intelligence and Online Harassment among Generation-Z in Pakistan: A Quantitative Study of Awareness, Victimization and Psychological Impact

  Zenodo (CERN European Organization for Nuclear Research) · 2026-01-24

  articleOpen accessSenior author
  PublisherDOI

• Addressing printability of poorly flowable drug by wet granulation: understanding interplays of formulation and process variables on critical quality attributes of sulfadiazine printlets

  International Journal of Pharmaceutics · 2026-03-29

  articleOpen accessSenior author
  PublisherOA PDFDOI

• India, US, and Other Foreign Regulatory Guidelines for Nanocomposites

  Apple Academic Press eBooks · 2026-01-27

  book-chapter
  PublisherDOI

• Cybercrime Awareness, Legal Literacy and Reporting Behavior among Generation-Z in Pakistan: Gendered Patterns and Policy Implications

  Open MIND · 2026-02-02

  articleSenior author
  DOI

• Appropriateness of Dissolution Methods on Evaluation of Digoxin Product Quality

  AAPS PharmSciTech · 2026-02-24

  articleOpen access

  The objectives of the present work were to simultaneously quantify digoxin (DGX) and its impurities by a common analytical method, compare dissolution data of a FDA approved commercial products by DGX tablets USP monograph, and apply the developed method to assess quality of the product. A UPLC method was developed and validated as per ICH guideline. An FDA approved formulation of DGX tablets was evaluated for quality (assay and dissolution), and stability by storing it at 30 °C/75% RH and 40 °C/75% RH conditions. Dissolution testing was performed in water and 0.1 N HCl as per the USP monograph. The UPLC method was specific, and linear over 100-2000 ng/ml with good accuracy > 98.6% and precision < 3.3% for all the analytes (DGX, digoxigenin, digoxigenin monodigitoxoside and digoxigenin bisdigitoxoside). The tablets met USP specification of assay > 98% and dissolution of > 85% in 20 min in water medium. However, the drug degrades into impurities in the acidic medium and fluorospectrometric method was non-specific in quantifying drug and impurities as per the USP monograph. Dissolution decreased by almost 30% on exposure to stability conditions and did not meet the specification due to an increase in the drug crystallinity as supported by the X-ray powder diffraction data. In summary, the developed UPLC method can be applied to assess the quality of DGX tablets, and dissolution testing in the acidic medium and fluorospectrometric method was non-discriminatory and non-specific for routine quality control test.

  PublisherOA PDFDOI

Frequent coauthors

• Ziyaur Rahman

  Texas A&M Health Science Center

  283 shared

• Eman M. Mohamed

  Texas A&M Health Science Center

  153 shared

• Sathish Dharani

  Texas A&M Health Science Center

  126 shared

• Indra K. Reddy

  101 shared

• Patrick J. Faustino

  Center for Drug Evaluation and Research

  97 shared

• Rakhi B. Shah

  89 shared

• Abhay Gupta

  Post Graduate Institute of Medical Education and Research

  84 shared

• Huiquan Wu

  Xiamen University of Technology

  76 shared

Labs

• Pharmaceutical SciencesPI

Education

• Ph.D. in Pharmaceutics (focus on industrial pharmacy and biopharmaceutics), Pharmacy and Administrative Science

  St. Johns University College of Pharmacy

  1992

• M.S. in Pharmaceutics (focus on physical pharmacy and drug delivery systems)

  Idaho State University

  1988

• M.S. in Pharmaceutical Technology

  Andhra University

  1984

• B.S. in Pharmacy

  Kakatiya University

  1982

Awards & honors

• Presidential Impact Fellow